Moreover, in neuroblastoma (z score = 3.22, p = 0.0013), endometrial carcinoma (z score = 2.49, p = 0.0127), and triple negative breast cancer (z score = 2.05, p = 0.04), higher CTL levels all suggested more favorable survival outcomes when STAT2 had relatively low expression (Supplementary Figures S17B–D). The gene discussed is STAT2; the disease is triple-negative breast carcinoma.